Search Results 381-390 of 14829 for MEN2A

1. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

   The primary purpose of this study is to evaluate the effectiveness of autologous genetically modified T-cells (ADP-A2M4) with Pembrolizumab in HLA-A*02 subjects ...

2. A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. Endpoint Determination Study Protocol - Clinical Trials

   The purpose of this study is to evaluate the most applicable endpoints for evaluation of the Biomerica InFoods® IBS product. Participation eligibility.

4. A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma - Mayo Clinic

   About this study. The purpose of the dose escalation part of the study is to characterize the safety and tolerability of ALN-BCAT as monotherapy and in ...

5. Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. Surgery - Doctors - Mayo Clinic

   Mayo Clinic Surgery offers deep expertise and a wide range of surgical care to tens of thousands of people each year.

8. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

   The purpose of this study is to evaluate DCR-PHXC in patients with primary hyperoxaluria type 1 (PH1) and severe renal impairment, with or without dialysis.

9. A Study to Evaluate Chemotherapy-Induced Nausea in Breast Cancer Patients - Mayo Clinic

   The identification of associations between fatigue, CIN and chemotherapy-induced changes in gut microbiome composition profiles will increase our understanding ...

10. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

    About this study. To evaluate and compare the efficacy and safety of regorafenib versus placebo in subjects with colorectal cancer (CRC) after curative ...